Clinical trial
The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients
NCT00307996 is registered in ClinicalTrials.gov with University of Shizuoka as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of CoQ10 Administration on the Oxidative and Antioxidative Markers in Hemodialysis Patients
- Lead sponsor
- University of Shizuoka
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2004
- Completion date
- December 31, 2004
- Enrollment
- 40
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
chronic renal failure, hemodialysis